Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer

Yu Zhu, Jing Li, Shrey Kanvinde, Zhiyi Lin, Stuart Hazeldine, Rakesh K Singh, David Oupicky

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Polycations are explored as carriers to deliver therapeutic nucleic acids. Polycations are conventionally pharmacological inert with the sole function of delivering therapeutic cargo. This study reports synthesis of a self-immolative polycation (DSS-BEN) based on a polyamine analogue drug N1,N11-bisethylnorspermine (BENSpm). The polycation was designed to function dually as a gene delivery carrier and a prodrug targeting dysregulated polyamine metabolism in cancer. Using a combination of NMR and HPLC, we confirm that the self-immolative polycation undergoes intracellular degradation into the parent drug BENSpm. The released BENSpm depletes cellular levels of spermidine and spermine and upregulates polyamine catabolic enzymes spermine/spermidine N1-acetyltransferase (SSAT) and spermine oxidase (SMO). The synthesized polycations form polyplexes with DNA and facilitate efficient transfection. Taking advantage of the ability of BENSpm to sensitize cancer cells to TNFα-induced apoptosis, we show that DSS-BEN enhances the cell killing activity of TNFα gene therapy. The reported findings validate DSS-BEN as a dual-function delivery system that can deliver a therapeutic gene and improve the outcome of gene therapy as a result of the intracellular degradation of DSS-BEN to BENSpm and the subsequent beneficial effect of BENSpm on dysregulated polyamine metabolism in cancer.

Original languageEnglish (US)
Pages (from-to)332-341
Number of pages10
JournalMolecular Pharmaceutics
Volume12
Issue number2
DOIs
StatePublished - Feb 2 2015

Fingerprint

Prodrugs
Polyamines
Genes
Neoplasms
Spermine
Genetic Therapy
Spermidine
Pharmaceutical Preparations
Nucleic Acids
Transfection
polycations
Up-Regulation
Therapeutics
High Pressure Liquid Chromatography
Pharmacology
Apoptosis
DNA
Enzymes

Keywords

  • TNFα
  • bisethylnorspermine
  • combination therapy
  • gene delivery
  • polyamine metabolism
  • polymeric prodrugs
  • self-immolative linker

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer. / Zhu, Yu; Li, Jing; Kanvinde, Shrey; Lin, Zhiyi; Hazeldine, Stuart; Singh, Rakesh K; Oupicky, David.

In: Molecular Pharmaceutics, Vol. 12, No. 2, 02.02.2015, p. 332-341.

Research output: Contribution to journalArticle

Zhu, Yu ; Li, Jing ; Kanvinde, Shrey ; Lin, Zhiyi ; Hazeldine, Stuart ; Singh, Rakesh K ; Oupicky, David. / Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer. In: Molecular Pharmaceutics. 2015 ; Vol. 12, No. 2. pp. 332-341.
@article{074db28fdb2a4787ad3baf534d98b74a,
title = "Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer",
abstract = "Polycations are explored as carriers to deliver therapeutic nucleic acids. Polycations are conventionally pharmacological inert with the sole function of delivering therapeutic cargo. This study reports synthesis of a self-immolative polycation (DSS-BEN) based on a polyamine analogue drug N1,N11-bisethylnorspermine (BENSpm). The polycation was designed to function dually as a gene delivery carrier and a prodrug targeting dysregulated polyamine metabolism in cancer. Using a combination of NMR and HPLC, we confirm that the self-immolative polycation undergoes intracellular degradation into the parent drug BENSpm. The released BENSpm depletes cellular levels of spermidine and spermine and upregulates polyamine catabolic enzymes spermine/spermidine N1-acetyltransferase (SSAT) and spermine oxidase (SMO). The synthesized polycations form polyplexes with DNA and facilitate efficient transfection. Taking advantage of the ability of BENSpm to sensitize cancer cells to TNFα-induced apoptosis, we show that DSS-BEN enhances the cell killing activity of TNFα gene therapy. The reported findings validate DSS-BEN as a dual-function delivery system that can deliver a therapeutic gene and improve the outcome of gene therapy as a result of the intracellular degradation of DSS-BEN to BENSpm and the subsequent beneficial effect of BENSpm on dysregulated polyamine metabolism in cancer.",
keywords = "TNFα, bisethylnorspermine, combination therapy, gene delivery, polyamine metabolism, polymeric prodrugs, self-immolative linker",
author = "Yu Zhu and Jing Li and Shrey Kanvinde and Zhiyi Lin and Stuart Hazeldine and Singh, {Rakesh K} and David Oupicky",
year = "2015",
month = "2",
day = "2",
doi = "10.1021/mp500469n",
language = "English (US)",
volume = "12",
pages = "332--341",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer

AU - Zhu, Yu

AU - Li, Jing

AU - Kanvinde, Shrey

AU - Lin, Zhiyi

AU - Hazeldine, Stuart

AU - Singh, Rakesh K

AU - Oupicky, David

PY - 2015/2/2

Y1 - 2015/2/2

N2 - Polycations are explored as carriers to deliver therapeutic nucleic acids. Polycations are conventionally pharmacological inert with the sole function of delivering therapeutic cargo. This study reports synthesis of a self-immolative polycation (DSS-BEN) based on a polyamine analogue drug N1,N11-bisethylnorspermine (BENSpm). The polycation was designed to function dually as a gene delivery carrier and a prodrug targeting dysregulated polyamine metabolism in cancer. Using a combination of NMR and HPLC, we confirm that the self-immolative polycation undergoes intracellular degradation into the parent drug BENSpm. The released BENSpm depletes cellular levels of spermidine and spermine and upregulates polyamine catabolic enzymes spermine/spermidine N1-acetyltransferase (SSAT) and spermine oxidase (SMO). The synthesized polycations form polyplexes with DNA and facilitate efficient transfection. Taking advantage of the ability of BENSpm to sensitize cancer cells to TNFα-induced apoptosis, we show that DSS-BEN enhances the cell killing activity of TNFα gene therapy. The reported findings validate DSS-BEN as a dual-function delivery system that can deliver a therapeutic gene and improve the outcome of gene therapy as a result of the intracellular degradation of DSS-BEN to BENSpm and the subsequent beneficial effect of BENSpm on dysregulated polyamine metabolism in cancer.

AB - Polycations are explored as carriers to deliver therapeutic nucleic acids. Polycations are conventionally pharmacological inert with the sole function of delivering therapeutic cargo. This study reports synthesis of a self-immolative polycation (DSS-BEN) based on a polyamine analogue drug N1,N11-bisethylnorspermine (BENSpm). The polycation was designed to function dually as a gene delivery carrier and a prodrug targeting dysregulated polyamine metabolism in cancer. Using a combination of NMR and HPLC, we confirm that the self-immolative polycation undergoes intracellular degradation into the parent drug BENSpm. The released BENSpm depletes cellular levels of spermidine and spermine and upregulates polyamine catabolic enzymes spermine/spermidine N1-acetyltransferase (SSAT) and spermine oxidase (SMO). The synthesized polycations form polyplexes with DNA and facilitate efficient transfection. Taking advantage of the ability of BENSpm to sensitize cancer cells to TNFα-induced apoptosis, we show that DSS-BEN enhances the cell killing activity of TNFα gene therapy. The reported findings validate DSS-BEN as a dual-function delivery system that can deliver a therapeutic gene and improve the outcome of gene therapy as a result of the intracellular degradation of DSS-BEN to BENSpm and the subsequent beneficial effect of BENSpm on dysregulated polyamine metabolism in cancer.

KW - TNFα

KW - bisethylnorspermine

KW - combination therapy

KW - gene delivery

KW - polyamine metabolism

KW - polymeric prodrugs

KW - self-immolative linker

UR - http://www.scopus.com/inward/record.url?scp=84961296183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961296183&partnerID=8YFLogxK

U2 - 10.1021/mp500469n

DO - 10.1021/mp500469n

M3 - Article

C2 - 25153488

AN - SCOPUS:84961296183

VL - 12

SP - 332

EP - 341

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 2

ER -